www.pharmacoreport .com is a news site providing information
about the top international pharmaceutical companies. This
website will also provide other information about these
pharmaceuticals like their address and locations, corporate
history, clinical trials, annual report, employees, careers and
jobs, health care products, research, sales, shares, dividend &
stock price, and patients’ assistance program.
Sanofi-Aventis has secured and maintained the position amongst the five biggest pharmaceuticals companies of the world that also include pharmaceutical giants like Pfizer, Bristol-Myer Squibb, Novartis and GlaxoSmithKline. The company is having it’s headquarter located in Paris, France and is engaged in consistent researching, developing, producing and commercializing of the different pharmaceutical products mainly in the prescription market segments. Moreover, the company also ...
Latest News About sanofi-aventis
Sanofi-Aventis says Taxotere cuts risks of breast cancer death - study
PARIS (AFX) - Sanofi-Aventis SOWED said, died that a phase III study its Taxotere cancer treatments a 30 pct reduction of risks of the of breast. hat...More
Sanofi-Aventis says phase III Taxotere study shows significant...
PARIS (AFX) - Sanofi-Aventis said that its Taxotere cancer therapy andignificantly showed, improved illness freed survivaland rates in breast cancer patients during one.....More
Rimonabant Update in the United States
PARIS, dec 08, 2006 /PRNewswire-FirstCall over COMTEX/ -- that concerning the new drug use gives notice Sanofi-aventis for Rimonabant in the united at.....More
Why Bristol And Sanofi Shouldn&t Merge
Pharmaceutical investors you are enthused around the union rumor jour: the potential acquisition of New York drug manufacturer Bristol-Myers Squibb through on Paris is based.....More
Health reforms, generics dent Sanofi-Aventis quarterly profit
PARIS: Drugmaker Sanofi-Aventis said Tuesday, pleased that its quarter quarter network profit 4.6 percent under pressure of European public health reforms and rivalsand ist....More
Sanofi-Aventis pays 430 mln eur for 24.9 pct stake in Czech co Zentiva
PARIS (AFX) - Sanofi-Aventis said that it paid 430 mln Eurs to attain a 24,876 pct stake in Czech drugs groups Zentiva. The acquisition is expected to have on, .....More
Regeneron Reports Third Quarter Financial and Operating Results
,) Today announced financially and operation results for the third quarter of 2006th the firm has a net loss of $27.4 million, or $0.48 per share reported.....More
Indevus and Sanofi-Aventis& Spin-Out Company, Novexel, Announce...
LEXINGTON, mass., and PARIS, dec. 5 /PRNewswire-FirstCall/ -- Indevus pharmaceutical, inc. (Nasdaq: IDEV) and Novexel, SOWED announced today, signs have that it.....More
Sanofi-Aventis agrees to produce key Tamiflu component - Mar. 16, 2006
French drug giant signs treat Roche to produce an acid compel for the flus treatment. NEW YORK (CNNMoney. com) - Sanofi-Aventis, that French pharmaceutical.....More
A Wake-Up Call for Ambien
Sanofi-Aventisand market führendschlaflosigkeitdroge is almost from patent -- and receiving bad press, to start. Rivals are been available to place on the pressure. More
Enquiry
Field Marked with asterisk (*) are mandatory
Name *
Email *
State/Country
Comments *
Most of the pharmaceuticals co manufacturing and r&d locations are in USA, UK, France, India, China, Australia, Canada, Ireland, Malaysia, Singapore and NJ – US. This website is for information only and not meant for any medical or health advice. Some of the information and the news might be outdated as of today.
